Guneet K Bindra

Dr. Guneet K Bindra

The University of Queensland, Brisbane, Queensland, Australia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2019 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
TPThanh Kha Phan
Thanh Kha Phan
SWScott A Williams
Scott A Williams
GBGuneet K Bindra
Guneet K Bindra
FLFung T Lay
Fung T Lay
Ivan PoonIvan Poon
Ivan Poon
MHMark Hulett
Mark Hulett

1 November 2019 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
TPThanh Kha Phan
Thanh Kha Phan
GBGuneet K Bindra
Guneet K Bindra
SWScott A. Williams
Scott A. Williams
Ivan PoonIvan Poon
Ivan Poon
MHMark Hulett
Mark Hulett

6 February 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
GBGuneet K Bindra
Guneet K Bindra
SWScott A. Williams
Scott A. Williams
FLFung T Lay
Fung T Lay
Amy Alexandra BaxterAmy Alexandra Baxter
Amy Alexandra Baxter
Ivan PoonIvan Poon
Ivan Poon
TPThanh Kha Phan
Thanh Kha Phan
Defensins form an integral part of the cationic host defence peptide (HDP) family, a key component of innate immunity. Apart from their antimicrobial and immunomodulatory activities, many HDPs exert multifaceted effects on tumour cells, notably direct oncolysis and/or inhibition of tumour cell migration. Therefore, HDPs have been explored as promising anticancer therapeutics. Human β-defensin 2 (HBD-2) represents a prominent member of human HDPs, being well-characterised for its potent pathogen-killing, wound-healing, cytokine-inducing and leukocyte-chemoattracting functions. However, its anticancer effects remain largely unknown. Recently, we demonstrated that HBD-2 binds strongly to phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), a key mediator of defensin-induced cell death and an instructional messenger during cell migration. Hence, in this study, we sought to investigate the lytic and anti-migratory effects of HBD-2 on tumour cells. Using various cell biological assays and confocal microscopy, we showed that HBD-2 killed tumour cells via acute lytic cell death rather than apoptosis. In addition, our data suggested that, despite the reported PI(4,5)P2 interaction, HBD-2 does not affect cytoskeletal-dependent tumour cell migration. Together, our findings provide further insights into defensin biology and informs future defensin-based drug development.

1 March 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
SWScott A. Williams
Scott A. Williams
FLFung T Lay
Fung T Lay
GBGuneet K Bindra
Guneet K Bindra
SBSuresh Banjara
Suresh Banjara
Ivan PoonIvan Poon
Ivan Poon
MHMark Hulett
Mark Hulett
Crocodilians are an order of ancient reptiles that thrive in pathogen-rich environments. The ability to inhabit these harsh environments is indicative of a resilient innate immune system. Defensins, a family of cysteine-rich cationic host defence peptides, are a major component of the innate immune systems of all plant and animal species, however crocodilian defensins are poorly characterised. We now show that the saltwater crocodile defensin CpoBD13 harbors potent antifungal activity that is mediated by a pH-dependent membrane-targeting action. CpoBD13 binds the phospholipid phosphatidic acid (PA) to form a large helical oligomeric complex, with specific histidine residues mediating PA binding. The utilisation of histidine residues for PA engagement allows CpoBD13 to exhibit differential activity at a range of environmental pH values, where CpoBD13 is optimally active in an acidic environment.

14 April 2022 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
NWNuchareenat Wiratpruk
Nuchareenat Wiratpruk
GBGuneet K Bindra
Guneet K Bindra
AHAlex Hamilton
Alex Hamilton
MHMark Hulett
Mark Hulett
PBPeter J. Barnard
Peter J. Barnard
Eight rhenium(i) N-heterocyclic carbene complexes in combination with N-acetyl amino acids ligands have been synthesised. The aquation rate constants for the complexes were evaluated and these compounds were cytotoxic in three cancer cell lines.

24 November 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
SISaba Islam
Saba Islam
MCMirren Charnley
Mirren Charnley
GBGuneet K Bindra
Guneet K Bindra
JRJulian Charles Ratcliffe
Julian Charles Ratcliffe
JZJiangtao Zhou
Jiangtao Zhou
NRNicholas Reynolds
Nicholas Reynolds
COVID-19 is primarily known as a respiratory disease caused by the virus SARS-CoV-2. However, neurological symptoms such as memory loss, sensory confusion, cognitive and psychiatric issues, severe headaches, and even stroke are reported in as many as 30% of cases and can persist even after the infection is over (so-called ‘long COVID’). These neurological symptoms are thought to be caused by brain inflammation, triggered by the virus infecting the central nervous system of COVID-19 patients, however we still don’t fully understand the mechanisms for these symptoms. The neurological effects of COVID-19 share many similarities to neurodegenerative diseases such as Alzheimer’s and Parkinson’s in which the presence of cytotoxic protein-based amyloid aggregates is a common etiological feature. Following the hypothesis that some neurological symptoms of COVID-19 may also follow an amyloid etiology we performed a bioinformatic scan of the SARS-CoV-2 proteome, detecting peptide fragments that were predicted to be highly amyloidogenic. We selected two of these peptides and discovered that they do rapidly self-assemble into amyloid. Furthermore, these amyloid assemblies were shown to be highly toxic to a neuronal cell line. We introduce and support the idea that cytotoxic amyloid aggregates of SARS-CoV-2 proteins are causing some of the neurological symptoms commonly found in COVID-19 and contributing to long COVID, especially those symptoms which are novel to long COVID in contrast to other post-viral syndromes.